Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-β-1b treatment in relapsing remitting MS
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):